Arvinas, Inc. (ARVN) vs Crescent Biopharma, Inc. (CBIO)
Arvinas, Inc. and Crescent Biopharma, Inc. are both Biotechnology companies. Arvinas, Inc. and Crescent Biopharma, Inc. are of similar size ($528.9M and $509.4M). Crescent Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 58.3×. Arvinas, Inc. grew revenue faster over the last twelve months: −15.1% against −45.1%. Arvinas, Inc. has the higher net margin (2.94% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Arvinas, Inc. leads on 10 and Crescent Biopharma, Inc. on 7.
Valuation
Profitability
| Metric | ARVN | CBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 97.16% | 19.72% | 65.16% |
| Operating margin | (5.72%) | 0.00% | 0.00% |
| Net margin | 2.94% | 0.00% | 0.00% |
| Free cash flow margin | (65.93%) | 0.00% | 0.00% |
| Return on equity | 1.59% | (112.14%) | (57.72%) |
| Return on assets | 1.17% | (97.08%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack